MC1116A1 - Procede et composition pour reduire la dose d'une substance biologiquement active tout en maintenant son effet biologique - Google Patents

Procede et composition pour reduire la dose d'une substance biologiquement active tout en maintenant son effet biologique

Info

Publication number
MC1116A1
MC1116A1 MC761221A MC1221A MC1116A1 MC 1116 A1 MC1116 A1 MC 1116A1 MC 761221 A MC761221 A MC 761221A MC 1221 A MC1221 A MC 1221A MC 1116 A1 MC1116 A1 MC 1116A1
Authority
MC
Monaco
Prior art keywords
dose
maintaining
reducing
composition
active substance
Prior art date
Application number
MC761221A
Other languages
English (en)
Original Assignee
Kockums Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kockums Chem filed Critical Kockums Chem
Publication of MC1116A1 publication Critical patent/MC1116A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/08—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing solids as carriers or diluents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/12—Powders or granules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00—Disinfection, sterilisation or deodorisation of air
    • A61L9/015—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/04—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating
    • A61L9/046—Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air without heating with the help of a non-organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/60—Particulates further characterized by their structure or composition
    • A61K2800/65—Characterized by the composition of the particulate/core
    • A61K2800/651—The particulate/core comprising inorganic material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
MC761221A 1976-06-29 1976-12-03 Procede et composition pour reduire la dose d'une substance biologiquement active tout en maintenant son effet biologique MC1116A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7607389A SE421042B (sv) 1976-06-29 1976-06-29 Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans

Publications (1)

Publication Number Publication Date
MC1116A1 true MC1116A1 (fr) 1977-08-12

Family

ID=20328328

Family Applications (1)

Application Number Title Priority Date Filing Date
MC761221A MC1116A1 (fr) 1976-06-29 1976-12-03 Procede et composition pour reduire la dose d'une substance biologiquement active tout en maintenant son effet biologique

Country Status (24)

Country Link
JP (1) JPS533512A (fr)
AR (1) AR221686A1 (fr)
AU (1) AU2611177A (fr)
BE (1) BE848892A (fr)
CA (1) CA1080500A (fr)
DD (1) DD130984A5 (fr)
DE (1) DE2652163A1 (fr)
DK (1) DK518476A (fr)
ES (1) ES460159A1 (fr)
FI (1) FI61637C (fr)
FR (1) FR2356430A1 (fr)
GB (1) GB1572718A (fr)
GR (1) GR63669B (fr)
IL (1) IL52243A (fr)
IN (1) IN145766B (fr)
IT (1) IT1064524B (fr)
LU (1) LU76238A1 (fr)
MC (1) MC1116A1 (fr)
NL (1) NL7613404A (fr)
NO (1) NO146974C (fr)
PL (1) PL199237A1 (fr)
PT (1) PT66663B (fr)
SE (1) SE421042B (fr)
ZA (1) ZA773259B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6026093B2 (ja) * 1978-03-14 1985-06-21 住友製薬株式会社 ゲフアルナート含有固型製剤の製造方法
IT1103817B (it) * 1978-06-27 1985-10-14 Guaber Spa Composizione deodorante granulare per posacenere
JPS5699415A (en) * 1979-12-21 1981-08-10 Glaxo Group Ltd Medicinal composition
DK204682A (da) * 1981-05-08 1982-11-09 Wellcome Found Parfumeafgivende materiale
NZ204861A (en) * 1982-07-20 1986-10-08 Nat Res Dev Sustained release device:trace element incorporated in cement
HU191244B (en) * 1984-01-06 1987-01-28 Egyt Gyogyszervegyeszeti Gyar Dust mixture of high propylene-glycol content and process for producing same
HU191245B (en) * 1984-01-06 1987-01-28 Egis Gyogyszergyar,Hu Process for the production of stbale pharmaceutical preparation against ketosis
GB8413191D0 (en) * 1984-05-23 1984-06-27 Beecham Group Plc Pharmaceutical composition
EP0215136B1 (fr) * 1985-09-02 1988-06-22 Artesan Pharma Gesellschaft mit beschränkter Haftung Agent actif thérapeutique contenant de l'hexétidine et méthode de préparation et application comme désinfectant vaginal
GB8713263D0 (en) * 1987-06-05 1987-07-08 Unilever Plc Spheroidal silica
DE19506141A1 (de) * 1995-02-22 1996-08-29 Hoechst Ag Verwendung von Aerogelen in der Pharmazie, in der Kosmetik und im Pflanzenschutz
EP0923312A1 (fr) * 1996-04-29 1999-06-23 K.U. Leuven Research & Development Composition pour administration orale presentant une haute efficacite d'absorption et procede de preparation de ladite composition
SG71877A1 (en) 1997-12-19 2000-04-18 Johnson & Johnson Consumer Novel powder compositions
DE69942205D1 (de) * 1998-08-13 2010-05-12 Cima Labs Inc Microemulsionen als feste dosisformen zur oralen verabreichung
JP5732043B2 (ja) * 2009-04-24 2015-06-10 オムヤ インターナショナル アーゲー 活性成分を放出制御するための粒状物質
HUE051406T2 (hu) 2012-11-14 2021-03-01 Grace W R & Co Biológiailag aktív anyagot és rendezetlen szervetlen oxidot tartalmazó kompozíciók

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5235736B2 (fr) * 1972-09-27 1977-09-10

Also Published As

Publication number Publication date
GB1572718A (en) 1980-07-30
PT66663B (en) 1978-11-13
PL199237A1 (pl) 1979-07-02
GR63669B (en) 1979-11-28
NO146974B (no) 1982-10-04
FI763304A (fr) 1977-12-30
FR2356430A1 (fr) 1978-01-27
IL52243A0 (en) 1977-08-31
JPS533512A (en) 1978-01-13
IN145766B (fr) 1978-12-16
ZA773259B (en) 1978-04-26
SE421042B (sv) 1981-11-23
DE2652163A1 (de) 1978-01-12
FR2356430B1 (fr) 1982-08-13
NO763947L (no) 1977-12-30
BE848892A (fr) 1977-03-16
IT1064524B (it) 1985-02-18
CA1080500A (fr) 1980-07-01
SE7607389L (sv) 1977-12-30
AU2611177A (en) 1978-12-21
DK518476A (da) 1977-12-30
LU76238A1 (fr) 1977-05-23
NO146974C (no) 1983-01-26
DD130984A5 (de) 1978-05-24
ES460159A1 (es) 1978-10-01
FI61637B (fi) 1982-05-31
AR221686A1 (es) 1981-03-13
FI61637C (fi) 1982-09-10
IL52243A (en) 1980-10-26
NL7613404A (nl) 1978-01-02
PT66663A (en) 1977-07-01

Similar Documents

Publication Publication Date Title
MC1116A1 (fr) Procede et composition pour reduire la dose d'une substance biologiquement active tout en maintenant son effet biologique
BE859824A (fr) Nouveaux derives d'hydantoine et composition pharmaceutique les contenant
BE880378A (fr) Procede d'abouchement anastomique
RO81371A (fr) Procede de preparation d'un support lipoide soluble pour la ligature des substances biologiquement actives
BE889698A (fr) Derives d'hydantoine, leur procede de preparation et leur application therapeutique
DK90182A (da) Biologisk aktive amidderivater
LU78330A1 (fr) Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant
BE881550A (fr) Melange de stereoisomeres de 2-(4-chlorophenyl)-isovalerate d'alpha-cyano-3-(4-halogenophenoxy)-benzyle, son procede de preparation et composition en contenant
FR2314195B1 (fr) Procede de preparation d'une matiere biologique immobilisee
LU81242A1 (fr) Composition en vue de reduire le taux de phenylalanine dans le sang,et son procede d'utilisation
HK43186A (en) Biologically active mixtures and salts of heterocyclic compounds
FR2465730B1 (fr) Procede de preparation de melanges selectifs de piperazine et d'ethylenediamine
PT76348A (fr) Isomere levogyre de la mequitazine son procede de preparation et medicaments le contenant
GB2095260B (en) Ubstance and immunoactive composition biologically active substance process for preparing the s0
DE3263167D1 (en) Physiologically active substance fa-5859, its derivative; their production and antidiabetic agents containing said compounds
BE884101A (fr) Derives d'isoquinoleine contenant du soufre, procedes pour leur preparation et composition pharmaceutiques les contenant
PT69537A (fr) Procede pour la preparation d'etheres dibenziliques substitues therapeutiquement actifs
PT77767A (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2513485B1 (fr) Herbicides contenant des derives carboxamido-thiocarbamates et procede pour la preparation des constituants actifs de ces herbicides
BE885731A (fr) Procede pour la preparation d'iminodiacetonitrile et iminodiacetonitrile ainsi produit
KR900700392A (ko) 초전도막 형성용 타아겟재
FR2519648B1 (fr) Culture biologique capable de causer la mort d'insectes ainsi que la composition et le procede utilises pour son application
FR2496466B1 (fr) Production d'hormone lactogene, placentaire, humaine
FR2342986A1 (fr) Procede de preparation d'halogenures d'acides (2-halogenoformyl)-vinyl)-organyl-phosphiniques
IT1136974B (it) "2-benzilossimorfoline biologicamente attive"

Legal Events

Date Code Title Description
YP Annual fee paid